The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.

about

The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.

Item

http://www.wikidata.org/entity/Q55128005

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The effect of atorvastatin tre ...... diseases: A case series study.

@en

The effect of atorvastatin tre ...... diseases: A case series study.

@nl

type

Item

label

The effect of atorvastatin tre ...... diseases: A case series study.

@en

The effect of atorvastatin tre ...... diseases: A case series study.

@nl

prefLabel

The effect of atorvastatin tre ...... diseases: A case series study.

@en

The effect of atorvastatin tre ...... diseases: A case series study.

@nl

P1476

The effect of atorvastatin tre ...... diseases: A case series study.

@en

P2093

Amir Raoufi

http://www.w3.org/2001/XMLSchema#string

Aram Toolabi

http://www.w3.org/2001/XMLSchema#string

Hassan Ahmadvand

http://www.w3.org/2001/XMLSchema#string

Mehdi Safariebrahimsarabie

http://www.w3.org/2001/XMLSchema#string

Nahid Hosseninejadmir

http://www.w3.org/2001/XMLSchema#string

P2860

Pleiotropic effects of statins

More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.

Antiatherogenic, hepatoprotective, and hypolipidemic effects of coenzyme Q10 in alloxan-induced type 1 diabetic rats.

Amelioration of lipid peroxidation in vivo and in vitro by Satureja khozestanica essential oil in alloxan-induced diabetic rats.

Metabolic origins and clinical significance of LDL heterogeneity.

Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein.

The antioxidant effects of statins.

Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.

Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.

Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

P304

282-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gholamreza Shahsavari

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29643923

http://www.w3.org/2001/XMLSchema#string

P932

5889919

http://www.w3.org/2001/XMLSchema#string